Penumbra (PEN) Total Current Liabilities (2014 - 2026)
Penumbra (PEN) posted quarterly Total Current Liabilities of $233.8 million for Q2 2026, up 48.18% year-over-year from $157.8 million in Q2 2025, and up 10.41% quarter-over-quarter from $211.7 million in Q1 2026.
Penumbra (PEN) Total Current Liabilities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Total Current Liabilities for 13 consecutive years, with $233.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 48.18% year-over-year to $233.8 million; the TTM figure through Jun 2026 stood at $233.8 million (up 48.18% YoY), while the FY2025 annual figure was $183.1 million, up 15.65% from the prior year.
- Total Current Liabilities improved to $233.8 million in Q2 2026 per PEN's latest filing, from $211.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $233.8 million in Q2 2026 and bottomed at $130.1 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $159.8 million across 5 years, with a median of $152.0 million in 2023.
- Annual changes were most pronounced in 2023 — Total Current Liabilities decreased 1.02% — and 2026, when it surged 48.18%.
- Penumbra's Total Current Liabilities stood at $144.9 million in 2022, then gained by 4.29% to $151.1 million in 2023, then advanced by 4.76% to $158.3 million in 2024, then gained by 15.65% to $183.1 million in 2025, then rose by 27.65% to $233.8 million in 2026.
- Business Quant data shows PEN's Total Current Liabilities at $233.8 million in Q2 2026, $211.7 million in Q1 2026, and $183.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 233.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 233.78 Mn |
| Mar 31, 2026 | 211.73 Mn |
| Dec 31, 2025 | 183.13 Mn |
| Sep 30, 2025 | 169.60 Mn |
| Jun 30, 2025 | 157.76 Mn |
| Mar 31, 2025 | 158.63 Mn |
| Dec 31, 2024 | 158.35 Mn |
| Sep 30, 2024 | 153.19 Mn |
| Jun 30, 2024 | 150.99 Mn |
| Mar 31, 2024 | 152.80 Mn |
| Dec 31, 2023 | 151.14 Mn |
| Sep 30, 2023 | 145.08 Mn |
| Jun 30, 2023 | 144.12 Mn |
| Mar 31, 2023 | 146.33 Mn |
| Dec 31, 2022 | 144.93 Mn |
| Sep 30, 2022 | 138.33 Mn |
| Jun 30, 2022 | 145.60 Mn |
| Mar 31, 2022 | 130.10 Mn |
| Dec 31, 2021 | 123.20 Mn |
| Sep 30, 2021 | 116.06 Mn |